Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
Vascular problems are the most common complications in diabetes. Substantial evidence from epidemiological and pathophysiological studies show that hyperglycemia is a major risk factor for macrovascular complications in patients with diabetes. (-)-Epigallocatechin-3-gallate (EGCG), the major catechi...
Main Author: | |
---|---|
Other Authors: | , , |
Format: | article |
Language: | eng |
Published: |
2017
|
Subjects: | |
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017001000401 |
Country: | Brazil |
Oai: | oai:scielo:S0100-879X2017001000401 |